Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: His wife beat a more formidable challenger. Molly Crosby, a 32-year-old mother of five, had been dealing with bouts of coughing and congestion all summer. Some preliminary exams in Green Bay showed a spot on her right lung. That led the Crosbys to the Mayo Clinic in Rochester, Minn., for additional tests. A carcinoid endocrine tumor was found. The tumor isn’t as dangerous as other forms of cancer but was disconcerting for an otherwise healthy, nonsmoker. “We found out the day before we reported to camp,” Crosby said on Wednesday. “We were at Mayo the two or three days leading up to training camp, when they did all their scans and got the final prognosis.” Crosby flew back to Green Bay for the start of training camp. After a subpar 2018 season, Crosby had to beat out Sam Ficken. Crosby managed to keep his focus and retained the job for a 13th season. “I’ve trained a long time in compartmentalizing different situations,” Crosby said. “Whenever I was home, I was fully home. The organization was unbelievable through training camp, just giving me time to be with Molly and be with the family and help where I could throughout the day and evening. I just tried to be fully in on both things. I have felt a lot of freedom in this. “I love doing what I’m doing but the importance of taking care of family and being there for Molly and the kids, when I look back on it, it was a special camp. I was able to really fully immerse in both things. It was nerve-wracking, too. Day in and day out, it was coming in, having to work and compete at a high level, and then going home and flowing back into a normal routine. Then, we’d sit down at night and you’d remember that surgery was coming and Molly had cancer. Those things were heavy.” That surgery was at the end of the preseason, with part of Molly’s right lung removed. While she will go back to Mayo for a scan in mid-October, Crosby said the doctors are positive they got rid of the tumor and she will not require radiation or chemotherapy. Since 2009, the NFL has held its annual “Crucial Catch” campaign to raise money for the American Cancer Society. It was a campaign that had already hit home for Crosby. A grandmother died of breast cancer and a sister-in-law is in her third year battling ovarian cancer. Now with his wife’s diagnosis, the fight against cancer has grown more meaningful. “That’s what it’s about is early detection,” he said. “It’s getting routine checkups. Don’t take it for granted. The numbers, with our technology, are amazing with prevention but treating it if you catch it early enough. That’s one of the big things is pushing that. Let’s try to get earlier detection so we can fight this thing. “With Molly’s cancer, it’s always been really important to me but I’m going to continue to push the charge forward and make sure that everybody gets the care. We feel so fortunate with the care that we got. Hopefully, everybody gets the same care and the same prognosis that we got.” The Packers (3-1) will play at the Dallas Cowboys (3-1) on Sunday. Some of Crosby’s finest professional moments have happened at AT&T Stadium. In the 2010 season, the Packers won the Super Bowl in Arlington. A playoff game in the 2016 season against the Cowboys marked the highlight of his career. His 56-yard field goal with 1:33 to play gave the Packers a 31-28 lead. Dallas tied the score, but Crosby booted a 51-yarder on the final play for a 34-31 victory. “The two minutes in that game were the most exciting two minutes I think I’ve ever had in a game,” he said. “To be able to execute it twice in that situation was awesome.” ___ More AP NFL: https://apnews.com/NFL and https://twitter.com/AP_NFL
[A]: Wife’s cancer diagnosis hits home for Packers’ Crosby.


[Q]: The release, while loaded with information about the research, fails to mention costs related to this new approach at any point. This is in spite of the fact that the paper provides what’s necessary to fulfill this criterion. The study authors wrote: “The easy access to the tumor site, the absence of the need for surgical removal of the tissue containing the T cells, the numbers of cells obtained with the harvest, and the ability to expand products in all patients with a relatively short process at a reasonable cost contrast sharply with several limitations of TIL ACT” (a current therapeutic approach to the disease). The release does a good job of spelling out the results of this phase 1 trial by providing data showing that MILs can target and kill cancer cells. It shows that in more than half of the study’s patients, their cancers had shrunk by at least half. In 15 of the 22 patients, their cancers did not progress for nearly a year after the MILs therapy. This wasn’t a controlled study, so it’s unclear how these patients would have fared without the MILs treatment, and the release could have attempted to provide some insight on that point. But we’re pleased that the release focuses appropriately on the apparent safety of the approach, rather than trying to make claims about survival benefits that aren’t supportable by this kind of small, uncontrolled study. The release also explains that the research provides information suggesting which patients might benefit best from this approach, and that other research at this cancer center is centered on testing this approach on different forms of cancer. We’ll give this criterion a satisfactory rating since the release specifically spells out, “None of the participants had serious side effects from the MILs therapy.” However, the study is really too small, and the time span too short, to comment substantively on the possible harms that might be seen if and when the treatment is more widely used. The research paper actually makes the point that the new procedure doesn’t require the “surgical removal of tissue,” and the procedure can be done at bedside rather than an operating suite. But the removal of cells from the bone marrow is still an invasive procedure that carries its own risk of infection or other problems. The release would have benefited from at least mentioning this aspect. The release makes a very good effort to objectively describe a technically complicated trial. It defines the trial at least twice as being “small” and calls it a “pilot,” suggesting that caution is appropriate when considering the results. It effectively explains the process involved in the treatments, including what was learned regarding the growth of cells in the lab after harvesting. It also points to the fact that while tumor-infiltrating lymphocytes (TILs) can only be retrieved from a quarter of the patient candidates for this technique, MILs were obtained from all of the patients in this study, suggesting that they may be a better tool for this therapy. Describing multiple myeloma as “the second most common cancer originating in the blood” doesn’t add much to our understanding of this disease. However, other statistics provide context regarding the scope of the problem in the United States. We’ll give it a pass. The funding sources for this research are listed in an end note in the release. No conflict of interest information is provided in the release, although the research paper discloses no conflicts. The release does mention that other forms of this adoptive T cell therapy use different cells, suggesting that other approaches are possible. The release also notes, “Three days before the injections of expanded MILs, patients received high doses of chemotherapy and a stem cell transplant, standard treatments for multiple myeloma.” The release points out that “several U.S. cancer centers have conducted similar experimental treatments” but adds that Johns Hopkins is the only one using the MIL cells. It also points to several other ongoing clinical trials at Hopkins that build on the findings of this small study. Using the terms “pilot” and “experimental,” the release signals that availability is very limited. We like the fact that the headline itself defines this as a “pilot” clinical trial and that the lede says that it is “what is believed to be the first small clinical trial of its kind.”  Those kinds of qualifiers both declare the specifics of the research and also provide informative caveats, allowing the reader to gauge how much credence to give to the findings. All too many other medical releases fail to provide this measured approach. This release is conservative throughout in its choice of language in describing this research which, based on its findings, might be ripe for exaggeration.
[A]: Pilot clinical trial finds injected immune cells safe in multiple myeloma patients


[Q]: "India has reported 471 cases of the coronavirus but health experts have warned that a big jump could be imminent, which would overwhelm the underfunded and crumbling public health infrastructure. On Monday, India confirmed two more deaths, bringing the total to nine. One was a 54-year-old man with no history of foreign travel, suggesting the start of community transmission of the virus, officials said. Streets were deserted in the national capital New Delhi and offices shut at the start of a lockdown to run till the end of the month. The government ordered commercial airlines to shut down domestic operations from midnight on Tuesday on top of a ban on international flights to try and contain the coronavirus. About 144 million people traveled on domestic flights last year. Rail travel, the lifeline of India, has already been suspended after thousands of people, mostly migrant workers, swarmed train stations to go home as businesses shut down and jobs dried up. Prime Minister Narendra Modi said many Indians were not taking the lockdown seriously. “Please save yourself, save your family, follow the instructions seriously,” he said on Twitter. The chief minister of the western state of Maharashtra, which has had the highest number of cases in India, ordered a curfew from Tuesday to force people indoors. “Despite multiple requests, people are not following rules. This compelled the government to impose the curfew,” Uddhav Thackeray said. The country’s main stock exchange located in Mumbai, the capital of Maharashtra, will however remain open, an official said. On Monday night, the Indian government said 30 states and union territories, or 548 districts, were under “complete lockdown.”   Newspapers canceled print runs in Mumbai after vendors refused to distribute them due to worries about the coronavirus, which emerged in China late last year and has spread around the world. Globally, cases exceed 325,000 with deaths topping 14,000. The Pakistani army said on Monday night it would help to impose nationwide restrictions to contain the spread of the coronavirus following a request from the government. Major General Babar Iftikhar said schools, malls, restaurants, cinemas, marriage halls, swimming pools and markets would be shut as of Monday with only eateries, pharmaceutical companies and medical stores allowed to remain open. Prime Minister Imran Khan had previously said he opposed such stringent measures because of the economic consequences for the poor. A spokesman did not immediately respond to a request for comment. Nepal ordered all land border crossings with India and China shut until March 29, saying thousands of people, most of them Nepali migrant workers, had crossed into Nepal in recent days from India, believing their homeland to be safer. Nepal reported its second case of the coronavirus on Monday, a citizen who had recently returned from France. “The closing of the border crossings is meant to ensure that no one infected with the virus crosses over to Nepal from India and China,” said Surya Thapa, an aide to Prime Minister K.P. Sharma Oli. Confirmed COVID-19 cases in South Asia:  *Pakistan   -   875  *India      -   471  *Sri Lanka  -    91   *Afghanistan  -    42  *Bangladesh  -    33  *Maldives     -    13   *Nepal       -     2  *Bhutan      -     2    ———————————-  TOTAL         - 1,529  https://www.mohfw.gov.in  hpb.health.gov.lk/en  http://covid.gov.pk  covid19.health.gov.mv/en"
[A]:
India shuts down flights, big cities as coronavirus toll rises in region.